A singular, focused company offering products in four areas: respiratory diagnostics, ventilation, airway management and operative care consumables. We manufacture and market more than 27,000 unique products for the diagnosis, treatment and monitoring of respiratory conditions in every stage of life. Vyaire was born of innovative brands that include AirLife®, Vital Signs®, Bear Medical Systems, Pulmonetic Systems, Sensormedics™, Viasys™ and many others; and we bring decades of industry leadership, clinical experience and unrivaled expertise. Now, as a single global "breathing company," we are focused on improving patient outcomes, increasing value for our customers and being a partner of choice.
Founded 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The aim in Respiratory is to transform asthma and COPD treatment through inhaled combinations at the core of care, biologics for the unmet needs of specific patient populations, and scientific advancements in disease modification. AstraZeneca operates in 100 countries and its innovative medicines are used by millions of patients. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.
MGC Diagnostics® and Medisoft are global medical technology companies dedicated to cardiorespiratory health solutions. Since 1977, we have been developing, manufacturing and marketing non-invasive diagnostic systems for the detection, classification and management of cardiorespiratory disease. This singular focus guides our strategy and defines our commitment to customers, employees and shareholders. These attributes make us uniquely qualified to solve today’s challenges and uncover solutions for tomorrow’s opportunities.
Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma and a half-life-optimized Anticalin protein to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris has established a diverse pipeline of Anticalin therapeutics for different indications and has strong R&D collaborations with AstraZeneca, Servier, Roche, Daiichi Sankyo, the Sanofi Group and others.
American Thoracic Society
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s more than 16,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.
OCTANe is building the SoCal of Tomorrow by connecting people, resources and capital to drive technology industry growth enabling new company creation and new jobs in Orange County. Its members represent Orange County technology executive leaders, entrepreneurs, investors, venture capitalists, academicians, and strategic advisors, all working together to fuel innovation in the OC. The organization has helped more than 800 companies via the LaunchPad™ SBDC accelerator. LaunchPad™ companies have received more than $700 million in investment and equity exits. These investments have supported the creation of more than 3,500 new jobs in Orange County. OCTANe annually welcomes more than 6,000 people to its programs and events. More than 2,000 business leaders throughout the Orange County region are OCTANe members.